- Home
- JD vs IDXX Comparison
JD vs IDXX Comparison
Compare JD & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JD | IDXX |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2B | 45.4B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | JD | IDXX |
|---|---|---|
| Price | $27.02 | $504.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $39.27 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 7.9M | 451.9K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 7.74 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $8.17 | $10.88 |
| Revenue Next Year | $6.01 | $8.59 |
| P/E Ratio | ★ $9.17 | $66.56 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $24.51 | $511.16 |
| 52 Week High | $36.86 | $769.98 |
Technical Indicators
Market Signals| Indicator | JD | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 31.07 | 32.00 |
| Support Level | $24.53 | N/A |
| Resistance Level | $27.63 | $583.93 |
| Average True Range (ATR) | 0.38 | 12.98 |
| MACD | -0.18 | -4.51 |
| Stochastic Oscillator | 7.59 | 6.35 |
Price Performance
Historical ComparisonAbout JD JD.com Inc.
JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2025. It offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace, and omnichannel businesses.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.